Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia

N N Osborne1

  • 1Nuffield Laboratory of Ophthalmology, University of Oxford, UK.

Visual Neuroscience
|February 18, 1999
PubMed

Insights

Memantine protects the retina from ischemia/reperfusion injury. This study shows memantine injections, given before or during ischemia, significantly reduce retinal damage and improve recovery in animal models.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Retinal ischemia/reperfusion (I/R) injury is a significant cause of vision loss.
  • Understanding protective mechanisms against I/R injury is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the neuroprotective potential of memantine against retinal I/R injury in rabbit and rat models.
  • To evaluate the impact of memantine on specific retinal biomarkers and structural integrity following I/R.

Main Methods:

  • Induction of retinal I/R injury using a suction cup procedure (rabbits) or elevated intraocular pressure (rats).
  • Administration of memantine via intravitreal injection (rabbits) or intraperitoneal injection (rats) at different time points.
  • Assessment of retinal function using electroretinography (ERG) and evaluation of protein expression (GABA, ChAT, alphaPKC, Thy-1) and retinal thickness via immunohistochemistry and morphometric analysis.

Main Results:

  • Ischemia/reperfusion caused significant changes in GABA and ChAT immunoreactivity and reduced ERG b-wave amplitude in rabbits.
  • Memantine administered before ischemia significantly reduced these changes and enhanced ERG recovery in rabbits.
  • In rats, ischemia/reperfusion altered ChAT and Thy-1 immunoreactivity and retinal thickness; memantine was protective when given at ischemia onset but not at reperfusion onset.

Conclusions:

  • Memantine demonstrates significant neuroprotective effects against retinal ischemia/reperfusion injury in both rabbit and rat models.
  • Timing of memantine administration is critical, with pre-ischemic or early ischemic treatment being most effective.
  • These findings suggest memantine as a potential therapeutic agent for preventing or mitigating retinal damage caused by ischemic events.

Related Concept Videos